AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / PHARMACEUTICAL PREPARATIONS
Arvinas, Inc
XNAS · usd
SIC 2834 · PHARMACEUTICAL PREPARATIONS
FIGI BBG00LW7YL08
7.30▼ 0.42 (-5.44%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
Trailing P/E
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close
7.72
Day's Range
7.20 – 7.70
52-Week Range
6.74 – 14.80
Volume
643.2K
Avg Volume
822.5K
Share Statistics
Shares Outstanding
Employees
246
Exchange
XNAS
Listed
2018-09-27
Share count as of July 31, 2026

Arvinas, Inc (ARVN) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about Arvinas, Inc (ARVN)
What is Arvinas, Inc's Market Cap?
Arvinas, Inc's Market Cap is $477.3M, based on as-reported figures from SEC (XBRL) filings.
What is Arvinas, Inc's Enterprise Value?
Arvinas, Inc's Enterprise Value is -$90.1M, based on as-reported figures from SEC (XBRL) filings.
What is Arvinas, Inc's Trailing P/E?
Arvinas, Inc's Trailing P/E is 51.3×, based on as-reported figures from SEC (XBRL) filings.
What is Arvinas, Inc's Price / Sales?
Arvinas, Inc's Price / Sales is 1.8×, based on as-reported figures from SEC (XBRL) filings.
What is Arvinas, Inc's EV / Revenue?
Arvinas, Inc's EV / Revenue is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Arvinas, Inc's EV / EBITDA?
Arvinas, Inc's EV / EBITDA is 5.9×, based on as-reported figures from SEC (XBRL) filings.
What is Arvinas, Inc's Revenue (TTM)?
Arvinas, Inc's Revenue (TTM) is $262.6M, based on as-reported figures from SEC (XBRL) filings.
What is Arvinas, Inc's Net Income (TTM)?
Arvinas, Inc's Net Income (TTM) is $9.3M, based on as-reported figures from SEC (XBRL) filings.
What is Arvinas, Inc's EBITDA?
Arvinas, Inc's EBITDA is -$15.2M, based on as-reported figures from SEC (XBRL) filings.
What is Arvinas, Inc's Diluted EPS (TTM)?
Arvinas, Inc's Diluted EPS (TTM) is 0.14, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · ARVNAs-filed SEC (XBRL) data
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Revenue
Revenue
YoY growth+1014.7%-91.7%-84.0%-59.1%
Operating expenses:
Cost of license revenue———
Research and development
General and administrative
Total operating expenses
% of revenue34.3%509.0%885.3%204.5%
Income (loss) from operations
% of revenue65.7%-409.0%-785.3%-104.5%
Other income
Other expense, net
Interest income, net
Total other income
Net income (loss) before income taxes—
Net income (loss)
% of revenue67.8%-369.2%-709.5%-83.8%
Basic (in dollars per share)
Diluted (in dollars per share)